The health care industry, like most industries, is exploring how to reap the benefits of increasingly powerful artificial intelligence-based technologies while managing the risks they pose.
The 2024 Medicare Physician Fee Schedule extends ten different pandemic flexibilities related to telehealth.
States, payers, and providers are looking for ways to expand access to telehealth services.
Prior to the COVID-19 public health emergency (PHE), the Centers for Medicare & Medicaid Services (CMS) evaluated changes to the Medicare Telehealth Services List (the List) through an annual rulemaking process.
Telehealth holds great potential as a tool to support improved access to and continuity of care. For a variety of reasons, this promise has been largely unfulfilled.
The COVID-19 pandemic catalyzed a dramatic rise in the use of telehealth nationwide to deliver services to individuals enrolled in Medicaid and the Children’s Health Insurance Program (CHIP).
In response to the large number of public comments received to its recent proposed telemedicine rules, the DEA is holding public listening sessions to consider a special registration for prescribing certain controlled substances via only a telemedicine encounter.
On July 13, the Centers for Medicare & Medicaid Services released its annual proposed rule updating the Medicare Physician Fee Schedule for calendar year 2024.
The use of telehealth increased exponentially in 2020 and 2021 as health care providers and patients responded to the COVID-19 pandemic.
On May 3, the Drug Enforcement Administration (DEA) issued a statement from Administrator Anne Milgram on COVID-19 telemedicine flexibilities for prescribing controlled substances in which the DEA noted that it has “decided to extend the current [public health emergency (PHE)] flexibilities ...